Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : M. T. Yin & R. Modarresi & E. Shane & F. Santiago & D. C. Ferris & D. J. McMahon & C. A. Zhang & S. Cremers & J. Laurence
- چاپ و سال / کشور: 2010
Description
Summary Ritonavir (RTV) is a commonly used antiretroviral associated with bone loss. We show that peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus (HIV)-positive women on RTV are more likely to differentiate into osteoclast-like cells when cultured with their own sera than PBMCs and sera from HIV. women or HIV+ on other antiretrovirals. Introduction RTV increases differentiation of human adherent PBMCs to functional osteoclasts in vitro, and antiretroviral regimens containing RTV have been associated with low bone mineral density (BMD) and bone loss. Methods BMD, proresorptive cytokines, bone turnover markers (BTMs), and induction of osteoclast-like cells from adherent PBMCs incubated either with macrophage colonystimulating factor (MCSF) and receptor activator of nuclear factor êB ligand (RANKL) or with autologous serum were compared in 51 HIV. and 68 HIV+ postmenopausal women. Results BMD was lower, and serum proresorptive cytokines and BTMs were higher in HIV+ versus HIV. women. Differentiation of osteoclast-like cells from adherent PBMCs exposed to either MCSF/RANKL or autologous serum was greater in HIV+ women. Induction of osteoclast-like cells was greater from PBMCs exposed to autologous sera from HIV+ women on RTV-containing versus other regimens (172±14% versus 110±10%, p<0.001). Serum-based induction of osteoclast-like cells from adherent PBMCs correlated with certain BTMs but not BMD. Conclusions HIV infection and antiretroviral therapy are associated with higher BTMs and increased differentiation of osteoclast-like cells from adherent PBMCs, especially in women on regimens containing RTV. HIV+ postmenopausal women receiving RTV may be at greater risk for bone loss.
Osteoporos Int (2011) 22:1459–1468 DOI 10.1007/s00198-010-1363-6 Received: 17 May 2010 / Accepted: 13 July 2010 / Published online: 4 August 2010
